These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3362823)

  • 1. [Use of antioxidants and lidase in pulmonary tuberculosis].
    Gur'eva IG; Andrzheiuk NI; Starostenko EV; Smirnova NA; Elistratova NA
    Probl Tuberk; 1988; (1):52-6. PubMed ID: 3362823
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comprehensive antibacterial therapy in combination with lidase of respiratory organ tuberculosis in children and adolescents].
    Firsova VA; Bolotnikova VA
    Probl Tuberk; 1979 Mar; (3):35-8. PubMed ID: 370821
    [No Abstract]   [Full Text] [Related]  

  • 3. [Radioisotope scanning of the lungs of patients with destructive pulmonary tuberculosis during treatment with antibacterial drugs and lidase].
    Grigaliunas AP
    Probl Tuberk; 1975; (5):45-7. PubMed ID: 1144343
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of lidase in the treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Grigaliunas AP
    Probl Tuberk; 1974; (11):26-30. PubMed ID: 4449837
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antioxidants--effective pathogenetic agents in the combined therapy of pulmonary tuberculosis].
    Gur'eva IG; Starostenko EV; Narovlianskaia SE
    Ter Arkh; 1987; 59(7):72-4. PubMed ID: 3672365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of antioxidants on lipid peroxidation and on liver function in patients with pulmonary tuberculosis].
    Skakun NL; Blikhar EI
    Farmakol Toksikol; 1986; 49(5):112-4. PubMed ID: 3770163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenetic therapy in pulmonary tuberculosis].
    Starostenko EV
    Probl Tuberk; 1989; (5):22-6. PubMed ID: 2748555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antioxidant effectiveness in preventing and eliminating the side effects of antibacterial preparations in pulmonary tuberculosis patients].
    Starostenko EV; Andrzheiuk NI; Salpagarov AM
    Probl Tuberk; 1987; (10):34-7. PubMed ID: 3422950
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modern aspects of the combined treatment of pulmonary tuberculosis in adolescents].
    Firsova VA; Rusakova LI; Gubkina MF; Ryzhova AP; Panova LV; Kobulashvili MG; Poluéktova FG; Iatskova TV
    Probl Tuberk; 2001; (7):21-3. PubMed ID: 11763555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enhancing treatment efficiency of patients with pulmonary tuberculosis by regional lymphotropic therapy].
    Ubaĭdullaev AM; Belotserkovskiĭ VG
    Probl Tuberk; 1999; (6):14-6. PubMed ID: 10715948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of bronchial pathology on the results of treatment of pulmonary tuberculosis].
    Shesterina MV; Kim ACh; Agafonnikova KI; Rzhavskov IuV; Barchakhova ZI
    Probl Tuberk; 1974; (8):21-3. PubMed ID: 4409353
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyaluronidase in complex treatment of tuberculous and metatuberculous lesions of the respiratory organs in children and adolescents].
    Kibrik BL; Khitrina GV
    Probl Tuberk; 1975; (3):48-51. PubMed ID: 1079600
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of hyaluronidase on morphologic ractions in experimental tuberculosis].
    Khitrina GV
    Probl Tuberk; 1971; 49(12):68-74. PubMed ID: 5159692
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antitubercular chemotherapy--its current status and outlook].
    Moisescu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(1):15-26. PubMed ID: 2847296
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of short-term treatment on the evolution toward chronicity of pulmonary tuberculosis].
    Basacopol A; Alexandrescu D; Stanciu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):177-9. PubMed ID: 2555905
    [No Abstract]   [Full Text] [Related]  

  • 16. [The evaluation of short-duration antitubercular chemotherapy (6 months) in rural areas].
    Serban G; Creţu D
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(4):368-71. PubMed ID: 2560252
    [No Abstract]   [Full Text] [Related]  

  • 17. [Short-term treatment (3+3) in pulmonary tuberculosis in adults].
    Ionescu C; Năstase M; Mihăescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):169-70. PubMed ID: 2555901
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy of destructive pulmonary tuberculosis with antioxidants and antihypoxic agents].
    Savula MM; Kravchenko NS; Poznanskiĭ AI
    Probl Tuberk; 1993; (5):18-20. PubMed ID: 8295877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of the chemotuberculinotherapy of patients with destructive pulmonary tuberculosis].
    Il'nitskiĭ IG
    Probl Tuberk; 1985; (4):36-8. PubMed ID: 4001106
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness of different chemotherapy regimens in newly detected patients with destructive pulmonary tuberculosis].
    Omarov TO; Shefer LB; V'iushkova SV; Abzharkenova ESh
    Probl Tuberk; 1987; (4):15-7. PubMed ID: 3601919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.